Hepb vacc 4 dose immunsup im
Products billed under this code include ENGERIX-B, Recombivax Hb.
Payment limit per 40 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include ENGERIX-B, Recombivax Hb.
Payment limit per 40 MCG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| ENGERIX-B | A-S MEDICATION SOLUTIONS LLC | 50090-1223-00 | 5 | $854.715 |
| ENGERIX-B | A-S MEDICATION SOLUTIONS LLC | 50090-1223-01 | 5 | $854.715 |
| Engerix-B | GlaxoSmithKline | 58160-0821-11 | 5 | $854.715 |
| Engerix-B | GlaxoSmithKline | 58160-0821-43 | 0.5 | $85.4715 |
| Engerix-B | GlaxoSmithKline | 58160-0821-52 | 5 | $854.715 |
| Recombivax Hb | Merck | 00006-4992-00 | 1 | $170.943 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $170.943 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted September 17, 2026 |
| 3Q26 | $170.943 | +$6.521 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted September 15, 2026 |
| 2Q26 | $164.422 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted September 15, 2026 |
| 1Q26 | $164.422 | +$23.67 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted September 15, 2026 |
| 4Q25 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted September 8, 2026 |
| 3Q25 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted March 10, 2026 |
| 2Q25 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted March 10, 2026 |
| 1Q25 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted December 19, 2025 |
| 4Q24 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 11, 2025 |
| 3Q24 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 11, 2025 |
| 2Q24 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted March 11, 2025 |
| 1Q24 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted December 19, 2024 |
| 4Q23 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted October 10, 2024 |
| 3Q23 | $140.752 | −$3.306 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 5, 2024 |
| 2Q23 | $144.058 | +$3.306 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted February 23, 2024 |
| 1Q23 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted December 6, 2023 |
| 4Q22 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 22, 2023 |
| 3Q22 | $140.752 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 9, 2023 |
| 2Q22 | $140.752 | −$0.004 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted December 14, 2022 |
| 1Q22 | $140.756 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 8, 2022 |
| 4Q21 | $140.756 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 2, 2022 |
| 3Q21 | $140.756 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted June 2, 2022 |
| 2Q21 | $140.756 | $0.00 | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted March 1, 2022 |
| 1Q21 | $140.756 | – | 40 MCG | Hepb vacc 4 dose immunsup im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.